Item Type | Name |
Concept
|
Prostate
|
Concept
|
Prostate-Specific Antigen
|
Academic Article
|
Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer.
|
Academic Article
|
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
|
Academic Article
|
The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.
|
Academic Article
|
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.
|
Academic Article
|
Advanced clinical states in prostate cancer.
|
Academic Article
|
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.
|
Academic Article
|
A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.
|
Academic Article
|
Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.
|
Academic Article
|
CYP17 polymorphisms and prostate cancer outcomes.
|
Academic Article
|
Oxidative DNA damage in the prostate may predispose men to a higher risk of prostate cancer.
|
Academic Article
|
Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence.
|
Academic Article
|
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist.
|
Academic Article
|
Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.
|
Academic Article
|
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
|
Academic Article
|
Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts.
|
Academic Article
|
Genomic Markers in Prostate Cancer Decision Making.
|
Academic Article
|
The basic biochemistry and molecular events of hormone therapy.
|
Academic Article
|
Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes.
|
Academic Article
|
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
|
Academic Article
|
Prediction models for prostate cancer outcomes: what is the state of the art in 2017?
|
Academic Article
|
Association of hepsin gene variants with prostate cancer risk and prognosis.
|
Academic Article
|
Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer.
|
Academic Article
|
Prostate cancer in men using testosterone supplementation.
|
Academic Article
|
Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.
|
Academic Article
|
Clinical roundtable monograph: new and emerging treatments for advanced prostate cancer.
|
Academic Article
|
The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinoma.
|
Academic Article
|
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
|
Academic Article
|
Influence of publication of US and European prostate cancer screening trials on PSA testing practices.
|
Academic Article
|
Vitamin D pathway gene variants and prostate cancer prognosis.
|
Academic Article
|
Neoadjuvant Enzalutamide Prior to Prostatectomy.
|
Academic Article
|
Targeted androgen pathway suppression in localized prostate cancer: a pilot study.
|
Academic Article
|
Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.
|
Academic Article
|
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
|
Academic Article
|
Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research.
|
Academic Article
|
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.
|
Academic Article
|
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.
|
Academic Article
|
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study.
|
Academic Article
|
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.
|
Academic Article
|
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.
|
Academic Article
|
Persistent intraprostatic androgen concentrations after medical castration in healthy men.
|
Academic Article
|
Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
|
Academic Article
|
Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.
|
Academic Article
|
Avoiding Undertreatment of Aggressive Prostate Cancer by Early Use of Chemotherapy.
|
Academic Article
|
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
|
Academic Article
|
Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men.
|
Academic Article
|
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
|
Academic Article
|
Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone.
|
Academic Article
|
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.
|
Academic Article
|
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.
|
Academic Article
|
Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
|
Academic Article
|
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator.
|
Academic Article
|
Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes.
|
Academic Article
|
Low-fat, low-glycemic load diet and gene expression in human prostate epithelium: a feasibility study of using cDNA microarrays to assess the response to dietary intervention in target tissues.
|
Academic Article
|
Male pattern baldness and prostate cancer risk in a population-based case-control study.
|
Academic Article
|
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.
|
Academic Article
|
A preliminary exploration of the feasibility of offering men information about potential prostate cancer treatment options before they know their biopsy results.
|
Academic Article
|
Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach.
|
Academic Article
|
Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort.
|
Academic Article
|
Adjuvant Chemotherapy for Prostate Cancer: The Long and Winding Road.
|
Academic Article
|
Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis.
|
Academic Article
|
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.
|
Academic Article
|
Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue.
|
Academic Article
|
Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation.
|
Academic Article
|
Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
|
Academic Article
|
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer.
|
Academic Article
|
Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort Study.
|
Academic Article
|
New and emerging treatments for advanced prostate cancer.
|
Academic Article
|
Prostate Cancer Screening in a New Era of Genetics.
|
Academic Article
|
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
|
Academic Article
|
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.
|
Academic Article
|
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.
|
Academic Article
|
What happens after an elevated PSA test: the experience of 13,591 veterans.
|
Academic Article
|
Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: a randomized, controlled trial.
|
Academic Article
|
Prostate cancer mortality following active surveillance versus immediate radical prostatectomy.
|
Academic Article
|
Surgical management of prostate cancer.
|
Academic Article
|
Active surveillance for prostate cancer: the role of the pathologist.
|
Academic Article
|
Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis.
|
Academic Article
|
Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men.
|
Academic Article
|
A dietary intervention to elicit rapid and complex dietary changes for studies investigating the effects of diet on tissues collected during invasive surgical procedures.
|
Academic Article
|
Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.
|
Academic Article
|
Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
|
Academic Article
|
Circumcision and the risk of prostate cancer.
|
Academic Article
|
Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.
|
Academic Article
|
Prostate cancer that is within 0.1 mm of the surgical margin of a radical prostatectomy predicts greater likelihood of recurrence.
|
Academic Article
|
New and novel markers for prostate cancer detection.
|
Academic Article
|
Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.
|
Academic Article
|
Castration-resistant prostate cancer: AUA Guideline.
|
Academic Article
|
Effects of screening on radical prostatectomy efficacy: the prostate cancer intervention versus observation trial.
|
Academic Article
|
A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a randomized controlled trial.
|
Academic Article
|
Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
|
Academic Article
|
Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification.
|
Academic Article
|
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.
|
Academic Article
|
The effect of demographic and clinical factors on the relationship between BMI and PSA levels.
|
Academic Article
|
Role of radical prostatectomy in metastatic prostate cancer: A review.
|
Academic Article
|
Differences in Upgrading of Prostate Cancer in Prostatectomies between Community and Academic Practices.
|
Academic Article
|
AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk.
|
Academic Article
|
Current status of focal primary therapy for prostate cancer.
|
Academic Article
|
Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T.
|
Academic Article
|
Plasma Fatty Acids as Surrogate for Prostate Levels.
|
Academic Article
|
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study.
|
Academic Article
|
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.
|
Academic Article
|
Practical guide to the use of abiraterone in castration resistant prostate cancer.
|
Academic Article
|
Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.
|
Academic Article
|
Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance.
|
Academic Article
|
Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.
|
Academic Article
|
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
|
Academic Article
|
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
|
Academic Article
|
Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.
|
Academic Article
|
Reply to Runqiang Yuan's Letter to the Editor re: James T. Kearns, Anna V. Faino, Lisa F. Newcomb, et al. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol 2018;73:706-12.
|
Academic Article
|
Continued Five-Alpha Reductase Inhibitor Use After Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the Canary Prostate Active Surveillance Study (PASS).
|
Academic Article
|
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS).
|
Academic Article
|
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
|
Academic Article
|
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement.
|
Academic Article
|
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.
|
Academic Article
|
Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.
|
Academic Article
|
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.
|
Academic Article
|
Contemporary grading for prostate cancer: implications for patient care.
|
Academic Article
|
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.
|
Academic Article
|
Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts.
|
Academic Article
|
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
|
Academic Article
|
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study (PASS).
|
Academic Article
|
PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
|
Academic Article
|
Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy.
|
Academic Article
|
The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study.
|
Academic Article
|
Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS).
|
Academic Article
|
Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study.
|
Academic Article
|
17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.
|
Academic Article
|
Active Surveillance for Prostate Cancer: A 2020 Vision.
|
Academic Article
|
Magnetic Resonance Imaging for the Detection of High-Grade Cancer in the Canary Prostate Active Surveillance Study.
|
Academic Article
|
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study.
|
Academic Article
|
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
|
Academic Article
|
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.
|
Academic Article
|
Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability.
|
Academic Article
|
Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians.
|
Academic Article
|
Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes.
|
Academic Article
|
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
|
Academic Article
|
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
|
Academic Article
|
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature.
|
Academic Article
|
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer.
|
Academic Article
|
25-year perspective on prostate cancer: Conquering frontiers and understanding tumor biology.
|
Academic Article
|
Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.
|
Academic Article
|
Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.
|
Academic Article
|
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.
|
Academic Article
|
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
|
Academic Article
|
Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer.
|
Academic Article
|
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.
|
Academic Article
|
Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.
|
Academic Article
|
Development and Validation of a Quantitative Reactive Stroma Biomarker (qRS) for Prostate Cancer Prognosis.
|
Academic Article
|
Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer.
|
Academic Article
|
Prognostic Genomic Biomarkers in Patients With Localized Prostate Cancer: Is Rising Utilization Justified by Evidence?
|
Academic Article
|
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up.
|
Academic Article
|
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.
|
Academic Article
|
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.
|
Academic Article
|
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging and Risk-Based Management.
|
Academic Article
|
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.
|
Academic Article
|
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity.
|
Academic Article
|
Point-Counterpoint: Active Surveillance Should Still Be Preferred Management for All (or Nearly All) Men With Low-risk Prostate Cancer.
|
Academic Article
|
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.
|
Academic Article
|
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.
|
Academic Article
|
Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.
|
Academic Article
|
Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS Cohort.
|
Academic Article
|
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: a Multi-Center Retrospective Study.
|
Academic Article
|
Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth.
|
Academic Article
|
Putting patients first to redefine prostate cancer classifications.
|
Academic Article
|
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.
|
Academic Article
|
Concurrent targeting of HDAC and PI3K to overcome phenotypic heterogeneity of castration-resistant and neuroendocrine prostate cancers.
|
Academic Article
|
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.
|
Academic Article
|
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.
|
Academic Article
|
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance.
|
Academic Article
|
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide.
|
Academic Article
|
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
|
Academic Article
|
Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data Linkage.
|
Academic Article
|
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting.
|
Academic Article
|
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort.
|